Skip to main content
AMS
NYSE Industrial Applications And Services

AMS Swings to $620K Q3 Loss Despite 6% Revenue Growth; Chairman Lends $2M Under Bank Forbearance

Arie Shkolnikov · Analysis by Wiseek AI
Sentiment info
Negative
Importance info
7
Price
$1.059
Mkt Cap
$7.04M
52W Low
$0.98
52W High
$2.39
52W Position info
8.0% above low
Off High info
56% below high
Rel. Volume info
4.1× avg
Market data snapshot near publication time

AMS is trading near its 52-week low of $0.98 (8.0% above the low) on elevated volume (4.1× avg).

Summary

American Shared Hospital Services grew Q3 revenue 6% to $7.6 million but posted a $620,000 net loss, while disclosing a Fifth Third Bank forbearance agreement and $2.0 million of subordinated financing from an entity controlled by its Executive Chairman.


Key Events · Earnings and Guidance · AMS

  • Q3 Revenue Up 6%, Loss Widens

    Total revenue rose 6.3% to $7.6 million from $7.2 million, but the net loss attributable to AMS widened to $620,000 ($0.09 per diluted share) from $17,000 a year earlier.

  • Nine-Month Loss Reaches $1.7M

    First nine months produced $23.1 million of revenue (up 13.7%) but a net loss of $1.746 million, or $0.26 per diluted share, versus $922,000 a year ago; adjusted EBITDA fell to $3.8 million from $4.6 million.

  • Bank Forbearance and Chairman Loan

    The company entered a Third Amendment and Forbearance Agreement with Fifth Third Bank in July 2026 and raised $2.0 million of subordinated financing from RCS/TIG Holdings LLC, controlled by Executive Chairman Ray Stachowiak.

  • Liquidity and Debt Position

    Cash, equivalents and restricted cash rose to $9.485 million from $3.712 million at year-end 2025, helped by $5.8 million of operating cash flow, against $15.7 million of current long-term debt.


Analysis · AMS · Industrial Applications And Services

Revenue is growing — up 6.3% in Q3 and 13.7% year to date, led by a 27% jump in Direct Patient Services — but the bottom line moved the wrong way: the quarterly net loss widened to $620,000 ($0.09 per share) from $17,000 a year ago, and nine-month losses reached $1.746 million. The more consequential disclosure sits in the balance sheet commentary: the company amended its Fifth Third Bank credit agreement and signed a forbearance agreement in July 2026, and its Executive Chairman's own entity, RCS/TIG Holdings, put in $2.0 million of subordinated financing to keep liquidity up. A bank forbearance plus insider subordinated debt is a distress marker, not routine financing — it means the lender granted relief rather than the company meeting original terms. Cash of $9.5 million against $15.7 million of current long-term debt leaves limited room, and management says it is still 'exploring longer-term capital structure alternatives,' which typically precedes a dilutive raise. On a roughly $7 million market cap, any equity issuance would be highly dilutive to the 6.65 million shares outstanding.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AMS was trading at $1.06 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7M. The 52-week trading range was $0.98 to $2.39. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AMS - Latest Insights